Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer
Ruifang Sun(Xi'an Jiaotong University), Changfu Xu(Respiratory Clinical Trials), Guangyan Lei, LV Wei-dong(Shanxi Medical University), Lumin Wang(Second Affiliated Hospital of Xi'an Jiaotong University), Zhigang Liu(Children's Hospital of Zhejiang University), Caixia Ding(Shanxi Medical University), Jia Liu(Peking University), Yong Yuan(Kunming Medical University)
Cited by 54
Related Papers
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
|Cell Reports|2018|1.3k
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
|Cancer Cell|2018|980